Showing 541 - 560 results of 2,092 for search '"chemotherapy"', query time: 0.05s Refine Results
  1. 541

    A Rare Case of Metastatic Primary Peritoneal Ependymoma: A Case Report and Literature Review by Ben Man Fei Cheung, Johnny Kin Sang Lau, Anthony W. I. Lo, Mai-Yee Luk, Kwok Keung Yuen

    Published 2020-01-01
    “…Etoposide containing the chemotherapy regimen is effective in the treatment of peritoneal ependymoma. …”
    Get full text
    Article
  2. 542

    Primary Diaphragmatic Dedifferentiated Liposarcoma in a Young Female Patient after Delivery by Shinya Sakata, Chieko Yoshida, Sho Saeki, Susumu Hirosako, Hidenori Ichiyasu, Hirotsugu Kohrogi

    Published 2016-01-01
    “…We initiated doxorubicin chemotherapy, and the tumor mass reduced. After that, we performed vascular embolization along with chemotherapy, but tumor size did not reduce. …”
    Get full text
    Article
  3. 543

    Role of immunotherapy in the overall survival of gastrointestinal cancer patients with liver metastases by Taoyuan M Beninato, Saber A Amin, Michael J Baine, Chi Lin

    Published 2024-12-01
    “…Chemoimmunotherapy with radiotherapy to metastatic sites (except liver) was associated with improved OS (HR 0.771; 95% CI 0.706–0.842; p < 0.001) compared to chemoradiation.Conclusion: Immunotherapy plus chemotherapy or chemoradiation was associated with improved OS compared with chemotherapy or chemoradiation without immunotherapy.…”
    Get full text
    Article
  4. 544
  5. 545

    Inhibition of KLF5 promotes ferroptosis via the ZEB1/HMOX1 axis to enhance sensitivity to oxaliplatin in cancer cells by Zheng Zhang, Huaxiang Xu, Junyi He, Qiangsheng Hu, Yuxin Liu, Zijin Xu, Wenhui Lou, Wenchuan Wu, Lei Zhang, Ning Pu, Chenye Shi, Yaolin Xu, Wenquan Wang, Liang Liu

    Published 2025-01-01
    “…These results reveal a critical role of KLF5 in sensitized chemotherapy of pancreatic cancer, and suggest that ferroptosis combined with platinum-based chemotherapy rather than gemcitabine-based chemotherapy is expected to bring better therapeutic effects.…”
    Get full text
    Article
  6. 546

    Hodgkin Lymphoma Mimicking Inflammatory Breast Carcinoma: A Rare Case with Diagnostic Challenge and Novel Treatment by Eleni Thodou, Maria Befani, George Triantafyllidis, Theodosia Choreftaki, George Kanellis, Nikolaos Giannakoulas

    Published 2019-01-01
    “…The patient after first-line chemotherapy developed relapse/refractory disease. Salvage chemotherapy regimens were applied with poor results and severe toxicity. …”
    Get full text
    Article
  7. 547

    Prognostic factors in hereditary breast cancer: A review by Ziske Maritska, Sarmoko

    Published 2024-08-01
    “…Despite this, BRCA mutation carriers exhibit higher sensitivity to platinum-based chemotherapy and PARP inhibitors, potentially improving outcomes. …”
    Get full text
    Article
  8. 548

    Small-Cell Lung Cancer with Positive Anti-NMDAR and Anti-AMPAR Antibodies Paraneoplastic Limbic Encephalitis by Sabina Boangher, Pascal Mespouille, Corina-Mihaela Filip, Sophie Goffette

    Published 2016-01-01
    “…After the completion of 3 cycles of chemotherapy her neurological status temporarily worsened. …”
    Get full text
    Article
  9. 549

    A Case of Anterior Spinal Artery Syndrome Caused by Streptococcus mitis Endocarditis by Aria Mahtabfar, Hamoon Eshraghi, Melroy D’Souza, William Berrigan, Kathleen Casey

    Published 2018-01-01
    “…A 78-year-old male with a history of gastroesophageal cancer treated with chemotherapy and radiation presented to the hospital after a fall at home. …”
    Get full text
    Article
  10. 550

    Successful Combined Treatment of a Patient with Borderline Resectable Liver Metastasis of Colorectal Cancer by O. Yu. Stukalova, A. A. Polikarpov, A. V. Moiseenko, D. A. Granov

    Published 2023-05-01
    “…Liver resection could not be performed due to the small future residual volume, and systemic chemotherapy was not effective. The patient underwent 3 cycles of regional chemotherapy. …”
    Get full text
    Article
  11. 551

    Concomitant Nephrotic Syndrome and Cryoglobulinemia in a Case of Malignant Mesothelioma by Kei Nagai, Hiroaki Tachi, Kohei Inoue, Atsushi Ueda

    Published 2022-01-01
    “…We recently encountered a patient with malignant mesothelioma coincident with nephrotic syndrome and cryoglobulinemia in the course of chemotherapy. A 60-year-old man employed as a building painter was diagnosed with malignant mesothelioma by lung biopsy two years earlier and was started on chemotherapy. …”
    Get full text
    Article
  12. 552

    Natural products as part of triple negative breast cancer by Yozlem Kobakova, Maria Moneva-Sakelarieva, Spiro Konstantinov, Georgi Momekov, Stefka Achkova Ivanova, Ventseslava Atanasova, Maria Chaneva, Radoslav Tododrov, Nikolay Bashev, Petar Atanasov

    Published 2025-01-01
    “…Chemotherapy is the most common of these options. The serious side effects of chemotherapy significantly limit its use. …”
    Get full text
    Article
  13. 553

    Paraneoplastic Dermatomyositis Associated with Metastatic Seminoma by Hidekazu Yoshie, Ryuto Nakazawa, Wataru Usuba, Hiroya Kudo, Yuichi Sato, Hideo Sasaki, Tatsuya Chikaraishi

    Published 2016-01-01
    “…Lymph node metastases completely disappeared and swallowing and respiration fully normalized after completing chemotherapy. We believe that this clinical success was due to our decision to initiate chemotherapy even in such a weak patient.…”
    Get full text
    Article
  14. 554

    Brentuximab Vedotin Treatment for Primary Refractory Hodgkin Lymphoma by Hung-Bo Wu, Shyh-An Yeh, Huei-Yung Chen

    Published 2013-01-01
    “…Up to 40% of patients with advanced Hodgkin lymphoma (HL) become refractory or relapsed after current standard chemotherapy, among which primary refractory HL confers a particularly poor outcome. …”
    Get full text
    Article
  15. 555

    Effect of primary tumor volume on survival of concurrent chemoradiotherapy in stage IV non‐small cell lung cancer by Xiaxia Chen, Wei Zhang, Lan Luo, Shimei Fu, Dongdong Cao, Shengfa Su, Qingsong Li, Wengang Yang, Yichao Geng, Bing Lu, Weiwei Ouyang

    Published 2024-09-01
    “…The number of median chemotherapy cycles was 4 (2–6), and the cut‐off value of the planning target volume (PTV) dose of the primary tumor was 63 Gy (30–76.5 Gy). …”
    Get full text
    Article
  16. 556

    NOS2 as a prognostic biomarker for early-onset colorectal cancer based on public data and clinical validation analysis by Chaoqun Xing, Lipeng Zhao, Weiwei Zou, Xie Peng, Xiao-Liang Xing, Jie Li

    Published 2025-02-01
    “…Sensitivity analysis of chemotherapy drugs showed that NOS2 was significantly correlated with several chemotherapy drugs, such as MG.132_1862, BMS.754807_2171, and GEN.317_1926. …”
    Get full text
    Article
  17. 557

    Pediatric Ovarian Growing Teratoma Syndrome by Rebecca M. Rentea, Aaron Varghese, Atif Ahmed, Alexander Kats, Michelle Manalang, Tazim Dowlut-McElroy, Richard J. Hendrickson

    Published 2017-01-01
    “…Ovarian immature teratoma is a germ cell tumor that comprises less than 1% of ovarian cancers and is treated with surgical debulking and chemotherapy depending on stage. Growing teratoma syndrome (GTS) is the phenomenon of the growth of mature teratoma elements with normal tumor markers during or following chemotherapy for treatment of a malignant germ cell tumor. …”
    Get full text
    Article
  18. 558

    Organ Function Preservation in Locally Advanced Low Rectal Cancer Through Total Neoadjuvant Therapy: A Case Report and Literature Review by Liu F, Yu L, Zhao Y, Li G, He X

    Published 2025-01-01
    “…After concurrent chemoradiotherapy, the patient underwent six additional cycles of consolidation chemotherapy, leading to a near-complete clinical response. …”
    Get full text
    Article
  19. 559

    Quasi-Complete Response of Classic Kaposi’s Sarcoma Treated with Weekly Paclitaxel by Zineb Benbrahim, Samia Arifi, Hafida Benhammane, Kaoutar Inani, Salim Gallouj, Meriem Meziane, Fatima Zahra Mernissi, Nawfel Mellas, Omar El Mesbahi

    Published 2013-01-01
    “…We report a patient treated with weekly Paclitaxel, as initial chemotherapy, for CKS presenting with multiple visceral involvement and having a contraindication for Bleomycin. …”
    Get full text
    Article
  20. 560

    A 5-Fluorouracil-Induced Hyperammonemic Encephalopathy Challenged with Capecitabine by Michael Chahin, Nithya Krishnan, Hardik Chhatrala, Marwan Shaikh

    Published 2020-01-01
    “…During both admissions, her symptoms resolved with IV hydration and cessation of chemotherapy. She was then successfully challenged with capecitabine (1000 mg/m2 daily), and additional hydration, and continued chemotherapy without recurrence of symptoms. …”
    Get full text
    Article